MTB
JAZZ icon

Mizuho Trust & Banking’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mizuho Trust & Banking’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-19,225
Closed -$3.32M – 871
2015
Q1 		$3.32M Buy
+19,225
New +$3.3M 0.01% 674

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mizuho Trust & Banking's JAZZ Position: Q2 2015 in Review

Mizuho Trust & Banking sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2015, closing a stake of 19,225 shares — an estimated $3.32M sold.

Mizuho Trust & Banking first reported a position in JAZZ in Q1 2015 and held it in 1 quarter. The position peaked at $3.32M in Q1 2015. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

  • Mizuho Trust & Banking reported no remaining Jazz Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Mizuho Trust & Banking sold 19,225 Jazz Pharmaceuticals shares in Q2 2015, an estimated $3.32M.
  • Mizuho Trust & Banking first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 1 quarter.
  • Mizuho Trust & Banking's Jazz Pharmaceuticals position peaked at $3.32M in Q1 2015.
  • 373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on Mizuho Trust & Banking's 13F filing for Q2 2015, filed 13 Aug 2015.